BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clark DV, Jahrling PB, Lawler JV. Clinical management of filovirus-infected patients. Viruses 2012;4:1668-86. [PMID: 23170178 DOI: 10.3390/v4091668] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Saeidnia S, Abdollahi M. Ebola hemorrhagic fever: current outbreak and progress in finding a cure. Daru 2014;22:70. [PMID: 25392051 DOI: 10.1186/s40199-014-0070-9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Wong G, Kobinger GP. Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin Microbiol Rev 2015;28:593-601. [PMID: 25972518 DOI: 10.1128/CMR.00014-15] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
3 Ewers EC, Pratt WD, Twenhafel NA, Shamblin J, Donnelly G, Esham H, Wlazlowski C, Johnson JC, Botto M, Hensley LE, Goff AJ. Natural History of Aerosol Exposure with Marburg Virus in Rhesus Macaques. Viruses 2016;8:87. [PMID: 27043611 DOI: 10.3390/v8040087] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
4 Galanopoulos M, Karianakis G, Amorginos K, Doukatas A, Gkeros F, Tsoukalas N, Papanikolaou I, Viazis N, Liatsos C. Laboratory manifestations and pathophysiological aspects of coronavirus disease 2019 pandemic: focusing on the digestive system. European Journal of Gastroenterology & Hepatology 2021;33:e59-65. [DOI: 10.1097/meg.0000000000002068] [Reference Citation Analysis]
5 Funk DJ, Kumar A. Ebola virus disease: an update for anesthesiologists and intensivists. Can J Anaesth 2015;62:80-91. [PMID: 25373801 DOI: 10.1007/s12630-014-0257-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
6 Duraffour S, Malvy D, Sissoko D. How to treat Ebola virus infections? A lesson from the field. Curr Opin Virol 2017;24:9-15. [PMID: 28410486 DOI: 10.1016/j.coviro.2017.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zheng X, Wong G, Zhao Y, Wang H, He S, Bi Y, Chen W, Jin H, Gai W, Chu D, Cao Z, Wang C, Fan Q, Chi H, Gao Y, Wang T, Feng N, Yan F, Huang G, Zheng Y, Li N, Li Y, Qian J, Zou Y, Kobinger G, Gao GF, Qiu X, Yang S, Xia X. Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection. Sci Rep 2016;6:24179. [PMID: 27067649 DOI: 10.1038/srep24179] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
8 West TE, von Saint André-von Arnim A. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc 2014;11:1341-50. [PMID: 25369317 DOI: 10.1513/AnnalsATS.201410-481PS] [Cited by in Crossref: 59] [Cited by in F6Publishing: 26] [Article Influence: 8.4] [Reference Citation Analysis]
9 Bebell LM, Riley LE. Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection. Obstet Gynecol 2015;125:1293-8. [PMID: 26000499 DOI: 10.1097/AOG.0000000000000853] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
10 Choi JH, Jonsson-Schmunk K, Qiu X, Shedlock DJ, Strong J, Xu JX, Michie KL, Audet J, Fernando L, Myers MJ, Weiner D, Bajrovic I, Tran LQ, Wong G, Bello A, Kobinger GP, Schafer SC, Croyle MA. A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection. Mol Pharm 2015;12:2712-31. [PMID: 25363619 DOI: 10.1021/mp500646d] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
11 Seesuay W, Jittavisutthikul S, Sae-Lim N, Sookrung N, Sakolvaree Y, Chaicumpa W. Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism. Emerg Microbes Infect 2018;7:41. [PMID: 29568066 DOI: 10.1038/s41426-018-0031-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
12 Torres M, Hansen KN, Jerrard D. Ebola: a review for emergency providers. Emerg Med Clin North Am 2015;33:e1-18. [PMID: 26065304 DOI: 10.1016/j.emc.2014.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wong SS, Wong SC. Ebola virus disease in nonendemic countries. J Formos Med Assoc 2015;114:384-98. [PMID: 25882189 DOI: 10.1016/j.jfma.2015.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Kendall RE, Gosser RA, Schulz LT, Trapskin PJ, Caponi B, Safdar N. Anti-diarrheal medication use in the treatment of Ebola virus-induced diarrhea. Travel Med Infect Dis 2015;13:205-6. [PMID: 25682446 DOI: 10.1016/j.tmaid.2015.01.003] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Bebell LM, Oduyebo T, Riley LE. Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res 2017;109:353-62. [PMID: 28398679 DOI: 10.1002/bdra.23558] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
16 Chippaux JP. Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga. J Venom Anim Toxins Incl Trop Dis 2014;20:44. [PMID: 25320574 DOI: 10.1186/1678-9199-20-44] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
17 Li H, Ying T, Yu F, Lu L, Jiang S. Development of therapeutics for treatment of Ebola virus infection. Microbes Infect 2015;17:109-17. [PMID: 25498866 DOI: 10.1016/j.micinf.2014.11.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
18 Parkes-Ratanshi R, Ssekabira U, Crozier I. Ebola in West Africa: be aware and prepare. Intensive Care Med 2014;40:1742-5. [PMID: 25253023 DOI: 10.1007/s00134-014-3497-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014;514:47-53. [PMID: 25171469 DOI: 10.1038/nature13777] [Cited by in Crossref: 666] [Cited by in F6Publishing: 598] [Article Influence: 83.3] [Reference Citation Analysis]
20 Heller JA, DeMaria S, Levine A, Heller BJ, Augoustides JG, Stone M, Silvay G, Goldberg A. Cardiovascular and Pulmonary Impact of the Ebola Virus: A Review of Current Literature and Practices. J Cardiothorac Vasc Anesth 2015;29:1672-6. [PMID: 26706795 DOI: 10.1053/j.jvca.2015.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Connor MJ Jr, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, Ströher U, Ribner BS, Franch HA. Successful delivery of RRT in Ebola virus disease. J Am Soc Nephrol 2015;26:31-7. [PMID: 25398785 DOI: 10.1681/ASN.2014111057] [Cited by in Crossref: 56] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
22 Bishop BM. Potential and emerging treatment options for Ebola virus disease. Ann Pharmacother 2015;49:196-206. [PMID: 25414384 DOI: 10.1177/1060028014561227] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
23 Roca A, Afolabi MO, Saidu Y, Kampmann B. Ebola: a holistic approach is required to achieve effective management and control. J Allergy Clin Immunol 2015;135:856-67. [PMID: 25843598 DOI: 10.1016/j.jaci.2015.02.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
24 Davidson E, Bryan C, Fong RH, Barnes T, Pfaff JM, Mabila M, Rucker JB, Doranz BJ. Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. J Virol 2015;89:10982-92. [PMID: 26311869 DOI: 10.1128/JVI.01490-15] [Cited by in Crossref: 99] [Cited by in F6Publishing: 65] [Article Influence: 14.1] [Reference Citation Analysis]
25 Martínez-Romero C, García-Sastre A. Against the clock towards new Ebola virus therapies. Virus Res 2015;209:4-10. [PMID: 26057711 DOI: 10.1016/j.virusres.2015.05.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
26 Fischer WA 2nd, Uyeki TM, Tauxe RV. Ebola virus disease: What clinicians in the United States need to know. Am J Infect Control 2015;43:788-93. [PMID: 26116335 DOI: 10.1016/j.ajic.2015.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
27 Wong G, Qiu X, Olinger GG, Kobinger GP. Post-exposure therapy of filovirus infections. Trends Microbiol 2014;22:456-63. [PMID: 24794572 DOI: 10.1016/j.tim.2014.04.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
28 Wong G, Qiu X. Development of experimental and early investigational drugs for the treatment of Ebola virus infections. Expert Opin Investig Drugs 2015;24:999-1011. [PMID: 26065319 DOI: 10.1517/13543784.2015.1052403] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Solano T, Gilbert GL, Kerridge IH, Nayyar V, Berry A. Ethical considerations in the management of Ebola virus disease. Med J Aust 2015;203:193-5e.1. [PMID: 26268293 DOI: 10.5694/mja15.00168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
30 Cao P, Bai H, Wang X, Che J. Role of the Ebola membrane in the protection conferred by the three-mAb cocktail MIL77. Sci Rep 2018;8:17628. [PMID: 30514891 DOI: 10.1038/s41598-018-35964-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Cerbino Neto J. Ethical issues in the management of patients with Ebola virus disease. Cad Saude Publica 2014;30:2256-8. [PMID: 25493980 DOI: 10.1590/0102-311xpe011114] [Reference Citation Analysis]
32 El Sayed SM, Abdelrahman AA, Ozbak HA, Hemeg HA, Kheyami AM, Rezk N, El-Ghoul MB, Nabo MM, Fathy YM. Updates in diagnosis and management of Ebola hemorrhagic fever. J Res Med Sci 2016;21:84. [PMID: 28163730 DOI: 10.4103/1735-1995.192500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Chiappelli F, Bakhordarian A, Thames AD, Du AM, Jan AL, Nahcivan M, Nguyen MT, Sama N, Manfrini E, Piva F, Rocha RM, Maida CA. Ebola: translational science considerations. J Transl Med 2015;13:11. [PMID: 25592846 DOI: 10.1186/s12967-014-0362-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
34 Aluisio AR, Yam D, Peters JL, Cho DK, Perera SM, Kennedy SB, Massaquoi M, Sahr F, Smit MA, Liu T, Levine AC. Impact of Intravenous Fluid Therapy on Survival Among Patients With Ebola Virus Disease: An International Multisite Retrospective Cohort Study. Clin Infect Dis 2020;70:1038-47. [PMID: 31050703 DOI: 10.1093/cid/ciz344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]